Prudential Financial’s Olema Pharmaceuticals OLMA Stock Holding History

Prudential Financial’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.64M	Buy	+110,150	New	+$2.45M	﹤0.01%	1399

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Prudential Financial's OLMA Position: Q1 2026 in Review

Prudential Financial opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 110,150 shares worth $1.64M. The stake represents ﹤0.01% of the portfolio and ranks #1399 among its holdings.

195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

Prudential Financial held 110,150 shares of Olema Pharmaceuticals worth $1.64M as of Q1 2026.
Olema Pharmaceuticals was a new Prudential Financial position in Q1 2026.
Olema Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1399 holding.
195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.